MT
Minh T. Truong
Highly rated in
22
conditions
Highly rated in
22
conditions
Check Dr. Minh T. Truong's experience treating your condition:
About Dr. Minh T. Truong

Minhtam Truong is an Oncologist in Boston, Massachusetts. Truong is highly rated in 22 conditions, according to our data. Her top areas of expertise are Tongue Cancer, Head and Neck Squamous Cell Carcinoma HNSCC, Laryngeal Cancer, and Throat Cancer. She is licensed to treat patients in Massachusetts. Truong is currently accepting new patients.

Her clinical research consists of co-authoring 76 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Minh T. Truong it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Minh T. Truong accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
830 Harrison Ave, Boston, MA 02118
Background & Education
Specialties
Radiation Oncology
Oncology
Licenses
Radiology in MA
Hospital Affiliations
Boston Medical Center
Languages Spoken
English
Vietnamese
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
The Feasibility and Outcome of Cyberknife® Stereotactic Radiosurgical Boost and Salvage Therapy for Head and Neck Cancer
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
View 6 Less Clinical Trials -

76 Total Publications

Oral cancer patients achieve comparable survival at high safety-net burden hospitals.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors